{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:00:54Z","timestamp":1783180854623,"version":"3.54.6"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth Analg Crit Care"],"DOI":"10.1186\/s44158-026-00393-9","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:44:12Z","timestamp":1777862652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Precision medicine in sepsis: lessons from the TIGRIS trial and the reawakening of targeted therapy"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-4088","authenticated-orcid":false,"given":"Toshiaki","family":"Iba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0895-6800","authenticated-orcid":false,"given":"Julie","family":"Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4141-9062","authenticated-orcid":false,"given":"Kunihiko","family":"Nagakari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4859-4747","authenticated-orcid":false,"given":"Ricard","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"issue":"19","key":"393_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14196691","volume":"14","author":"L La Via","year":"2025","unstructured":"La Via L, Maniaci A, Lentini M, Cuttone G, Ronsivalle S, Tutino S, Rubulotta FM, Nunnari G, Marino A (2025) The burden of sepsis and septic shock in the intensive care unit. J Clin Med 14(19):6691","journal-title":"J Clin Med"},{"issue":"8","key":"393_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801\u2013810","journal-title":"JAMA"},{"issue":"9","key":"393_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369(9):840\u2013845","journal-title":"N Engl J Med"},{"key":"393_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL (2016) Sepsis and septic shock. Nat Rev Dis Primers 2:16045","journal-title":"Nat Rev Dis Primers"},{"issue":"20","key":"393_CR5","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, Chang CH, Elliott CF, Xu Z, Berry S, Clermont G, Cooper G, Gomez H, Huang DT, Kellum JA, Mi Q, Opal SM, Talisa V, van der Poll T, Visweswaran S, Vodovotz Y, Weiss JC, Yealy DM, Yende S, Angus DC (2019) Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA 321(20):2003\u20132017","journal-title":"JAMA"},{"issue":"4","key":"393_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.molmed.2014.01.007","volume":"20","author":"JC Marshall","year":"2014","unstructured":"Marshall JC (2014) Why have clinical trials in sepsis failed? Trends Mol Med 20(4):195\u2013203","journal-title":"Trends Mol Med"},{"issue":"6","key":"393_CR7","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","volume":"41","author":"DM Payen","year":"2015","unstructured":"Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, Pottecher J, Joannes-Boyau O, Martin-Lefevre L, Jabaudon M, Mimoz O, Coudroy R, Ferrandi\u00e8re M, Kipnis E, Vela C, Chevallier S, Mallat J, Robert R, ABDOMIX Group (2015) Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med 41(6):975\u2013984","journal-title":"Intensive Care Med"},{"issue":"14","key":"393_CR8","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2018.14618","volume":"320","author":"RP Dellinger","year":"2018","unstructured":"Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, Palevsky PM, Weisberg LS, Schorr CA, Trzeciak S, Walker PM, EUPHRATES Trial Investigators (2018) Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. JAMA 320(14):1455\u20131463","journal-title":"JAMA"},{"issue":"20","key":"393_CR9","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2019.5358","volume":"321","author":"JL Vincent","year":"2019","unstructured":"Vincent JL, Francois B, Zabolotskikh I, Daga MK, Lascarrou JB, Kirov MY, Pettil\u00e4 V, Wittebole X, Meziani F, Mercier E, Lobo SM, Barie PS, Crowther M, Esmon CT, Fareed J, Gando S, Gorelick KJ, Levi M, Mira JP, Opal SM, Parrillo J, Russell JA, Saito H, Tsuruta K, Sakai T, Fineberg D, SCARLET Trial Group (2019) Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial. JAMA 321(20):1993\u20132002","journal-title":"JAMA"},{"key":"393_CR10","unstructured":"https:\/\/spectraldx.com\/spectral-medical-and-vantive-announce-topline-results-from-spectrals-tigris-trial-evaluating-pmx-hemoadsorption-therapy-for-endotoxic-septic-shock\/ (accessed on Mar. 23, 2026)"},{"issue":"1","key":"393_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1538-7836.2005.01697.x","volume":"4","author":"J Kienast","year":"2006","unstructured":"Kienast J, Juers M, Wiedermann CJ, Hoffmann JN, Ostermann H, Strauss R, Keinecke HO, Warren BL, Opal SM, KyberSept investigators (2006) Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 4(1):90\u20137","journal-title":"J Thromb Haemost"},{"issue":"10","key":"393_CR12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJM200103083441001","volume":"344","author":"GR Bernard","year":"2001","unstructured":"Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344(10):699\u2013709","journal-title":"N Engl J Med"},{"issue":"22","key":"393_CR13","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","volume":"366","author":"VM Ranieri","year":"2012","unstructured":"Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, G\u00e5rdlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD, PROWESS-SHOCK Study Group (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366(22):2055\u201364","journal-title":"N Engl J Med"},{"issue":"15","key":"393_CR14","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","volume":"286","author":"BL Warren","year":"2001","unstructured":"Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, P\u00e9nzes I, K\u00fcbler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM, KyberSept Trial Study Group (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286(15):1869\u201378","journal-title":"JAMA"},{"issue":"2","key":"393_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jama.290.2.238","volume":"290","author":"E Abraham","year":"2003","unstructured":"Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettil\u00e4 V, Sprung CL, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA, OPTIMIST Trial Study Group (2003) Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 290(2):238\u201347","journal-title":"JAMA"},{"issue":"3","key":"393_CR16","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1152\/physrev.00037.2012","volume":"93","author":"KN Iskander","year":"2013","unstructured":"Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, Kurosawa S, Stepien D, Valentine C, Remick DG (2013) Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev 93(3):1247\u20131288","journal-title":"Physiol Rev"},{"issue":"3","key":"393_CR17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/bja\/aev163","volume":"115","author":"JP Moore","year":"2015","unstructured":"Moore JP, Dyson A, Singer M, Fraser J (2015) Microcirculatory dysfunction and resuscitation: why, when, and how. Br J Anaesth 115(3):366\u2013375","journal-title":"Br J Anaesth"},{"issue":"4","key":"393_CR18","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201810128","volume":"12","author":"JM Cavaillon","year":"2020","unstructured":"Cavaillon JM, Singer M, Skirecki T (2020) Sepsis therapies: learning from 30 years of failure of translational research to propose new leads. EMBO Mol Med 12(4):e10128","journal-title":"EMBO Mol Med"},{"issue":"1","key":"393_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01766-7","volume":"9","author":"M Cao","year":"2023","unstructured":"Cao M, Wang G, Xie J (2023) Immune dysregulation in sepsis: experiences, lessons and perspectives. Cell Death Discov 9(1):465","journal-title":"Cell Death Discov"},{"issue":"2","key":"393_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/35100529","volume":"1","author":"R Medzhitov","year":"2001","unstructured":"Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1(2):135\u2013145","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"393_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1189\/jlb.3RU0316-151R","volume":"100","author":"RS Munford","year":"2016","unstructured":"Munford RS (2016) Endotoxemia-menace, marker, or mistake? J Leukoc Biol 100(4):687\u2013698","journal-title":"J Leukoc Biol"},{"issue":"7203","key":"393_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454(7203):428\u2013435","journal-title":"Nature"},{"issue":"2","key":"393_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0022-1759(98)00003-9","volume":"212","author":"AD Romaschin","year":"1998","unstructured":"Romaschin AD, Harris DM, Ribeiro MB, Paice J, Foster DM, Walker PM, Marshall JC (1998) A rapid assay of endotoxin in whole blood using autologous neutrophil dependent chemiluminescence. J Immunol Methods 212(2):169\u2013185","journal-title":"J Immunol Methods"},{"issue":"1","key":"393_CR24","doi-asserted-by":"publisher","first-page":"H24","DOI":"10.1152\/ajpheart.00034.2016","volume":"311","author":"M Miranda","year":"2016","unstructured":"Miranda M, Balarini M, Caixeta D, Bouskela E (2016) Microcirculatory dysfunction in sepsis: pathophysiology, clinical monitoring, and potential therapies. Am J Physiol Heart Circ Physiol 311(1):H24-35","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"393_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1086\/422254","volume":"190","author":"JC Marshall","year":"2004","unstructured":"Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal S, Abraham E, Brett SJ, Smith T, Mehta S, Derzko A, Romaschin A, MEDIC study (2004) Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 190(3):527\u201334","journal-title":"J Infect Dis"},{"issue":"9","key":"393_CR26","volume":"7","author":"L Molinari","year":"2025","unstructured":"Molinari L, Tidswell MA, Al-Khafaji A, Davison D, Galphin C, Kamaluddin E, Foster DM, Kellum JA (2025) Organ failure, endotoxin activity, and mortality in septic shock. Crit Care Explor 7(9):e1308","journal-title":"Crit Care Explor"},{"issue":"7","key":"393_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG (2017) The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol 17(7):407\u2013420","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"393_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52735-8","volume":"14","author":"S Harm","year":"2024","unstructured":"Harm S, Schildb\u00f6ck C, Cont D, Weber V (2024) Heparin enables the reliable detection of endotoxin in human serum samples using the Limulus amebocyte lysate assay. Sci Rep 14(1):2410","journal-title":"Sci Rep"},{"issue":"2","key":"393_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1128\/CMR.8.2.268","volume":"8","author":"JC Hurley","year":"1995","unstructured":"Hurley JC (1995) Endotoxemia: methods of detection and clinical correlates. Clin Microbiol Rev 8(2):268\u2013292","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"393_CR30","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1086\/315093","volume":"180","author":"SM Opal","year":"1999","unstructured":"Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, Pribble JP, Lemke JH (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180(5):1584\u20131589","journal-title":"J Infect Dis"},{"issue":"5","key":"393_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9050536","volume":"9","author":"H Tamura","year":"2021","unstructured":"Tamura H, Reich J, Nagaoka I (2021) Outstanding contributions of LAL technology to pharmaceutical and medical science: review of methods, progress, challenges, and future perspectives in early detection and management of bacterial infections and invasive fungal diseases. Biomedicines 9(5):536","journal-title":"Biomedicines"},{"issue":"8","key":"393_CR32","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1073\/pnas.75.8.3993","volume":"75","author":"SK Maitra","year":"1978","unstructured":"Maitra SK, Schotz MC, Yoshikawa TT, Guze LB (1978) Determination of lipid A and endotoxin in serum by mass spectroscopy. Proc Natl Acad Sci U S A 75(8):3993\u20133997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"393_CR33","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/gerona\/gls178","volume":"67","author":"JR Stehle Jr","year":"2012","unstructured":"Stehle JR Jr, Leng X, Kitzman DW, Nicklas BJ, Kritchevsky SB, High KP (2012) Lipopolysaccharide-binding protein, a surrogate marker of microbial translocation, is associated with physical function in healthy older adults. J Gerontol A Biol Sci Med Sci 67(11):1212\u20138","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"393_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000315914","volume":"167","author":"JC Marshall","year":"2010","unstructured":"Marshall JC (2010) Endotoxin in the pathogenesis of sepsis. Contrib Nephrol 167:1\u201313","journal-title":"Contrib Nephrol"},{"issue":"20","key":"393_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13202603","volume":"13","author":"T Iba","year":"2025","unstructured":"Iba T, Okada H, Miki T, Mineshima M, Nagaoka I (2025) Endotoxin activity assay-guided patient selection for Polymyxin B hemoperfusion: lessons from the TIGRIS trial and future directions. Healthcare (Basel) 13(20):2603","journal-title":"Healthcare (Basel)"},{"issue":"3","key":"393_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/cc13912","volume":"18","author":"C Ronco","year":"2014","unstructured":"Ronco C, Klein DJ (2014) Polymyxin B hemoperfusion: a mechanistic perspective. Crit Care 18(3):309","journal-title":"Crit Care"},{"key":"393_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000315918","volume":"167","author":"S Vesentini","year":"2010","unstructured":"Vesentini S, Soncini M, Fiore GB, Redaelli A (2010) Mechanisms of Polymyxin B endotoxin removal from extracorporeal blood flow: molecular interactions. Contrib Nephrol 167:45\u201354","journal-title":"Contrib Nephrol"},{"issue":"11","key":"393_CR38","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1055\/a-2091-7006","volume":"123","author":"ATA Sachetto","year":"2023","unstructured":"Sachetto ATA, Mackman N (2023) Monocyte tissue factor expression: lipopolysaccharide induction and roles in pathological activation of coagulation. Thromb Haemost 123(11):1017\u20131033","journal-title":"Thromb Haemost"},{"issue":"23","key":"393_CR39","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1001\/jama.2009.856","volume":"301","author":"DN Cruz","year":"2009","unstructured":"Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C (2009) Early use of Polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 301(23):2445\u20132452","journal-title":"JAMA"},{"issue":"11","key":"393_CR40","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Hylander M\u00f8ller M, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med 49(11):e1063\u2013e1143","journal-title":"Crit Care Med"},{"key":"393_CR41","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT03901807?cond=sepsis&intr=polymyxin%20b%20hemoperfusion&term=TIGRIS&rank=1 (accessed on Mar. 23, 2026)"},{"key":"393_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-025-00835-6","author":"T Iba","year":"2025","unstructured":"Iba T, Helms J, Nagaoka I, Mineshima M, Ferrer R (2025) TIGRIS and EUPHRATES eventually join and provide new evidence: a narrative review of the Polymyxin B hemoperfusion. J Intensive Care. https:\/\/doi.org\/10.1186\/s40560-025-00835-6","journal-title":"J Intensive Care"},{"key":"393_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40560-019-0386-0","volume":"7","author":"T Iba","year":"2019","unstructured":"Iba T, Klein DJ (2019) The wind changed direction and the big river still flows: From EUPHRATES to TIGRIS. J Intensive Care 7:31","journal-title":"J Intensive Care"},{"key":"393_CR44","doi-asserted-by":"publisher","DOI":"10.1055\/a-2675-6068","author":"T Iba","year":"2025","unstructured":"Iba T, Maier CL, Scarlatescu E, Levy JH (2025) Introducing the new definition and diagnostic criteria of disseminated intravascular coagulation released by the International Society on Thrombosis and Haemostasis in 2025. Semin Thromb Hemost. https:\/\/doi.org\/10.1055\/a-2675-6068","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"393_CR45","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/jth.14578","volume":"17","author":"T Iba","year":"2019","unstructured":"Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M, Scientific and Standardization Committee on DIC, and the Scientific and Standardization Committee on Perioperative and Critical Care of the International Society on Thrombosis and Haemostasis (2019) Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost 17(11):1989\u20131994","journal-title":"J Thromb Haemost"},{"issue":"2","key":"393_CR46","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/life13020350","volume":"13","author":"AG Tsantes","year":"2023","unstructured":"Tsantes AG, Parastatidou S, Tsantes EA, Bonova E, Tsante KA, Mantzios PG, Vaiopoulos AG, Tsalas S, Konstantinidi A, Houhoula D, Iacovidou N, Piovani D, Nikolopoulos GK, Sokou R (2023) Sepsis-induced coagulopathy: An update on pathophysiology, biomarkers, and current guidelines. Life 13(2):350","journal-title":"Life"},{"key":"393_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1144229","volume":"14","author":"E Maneta","year":"2023","unstructured":"Maneta E, Aivalioti E, Tual-Chalot S, Emini Veseli B, Gatsiou A, Stamatelopoulos K, Stellos K (2023) Endothelial dysfunction and immunothrombosis in sepsis. Front Immunol 14:1144229","journal-title":"Front Immunol"},{"issue":"1","key":"393_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1055\/s-0039-1694995","volume":"46","author":"T Iba","year":"2020","unstructured":"Iba T, Levi M, Levy JH (2020) Sepsis-induced coagulopathy and disseminated intravascular coagulation. Semin Thromb Hemost 46(1):89\u201395","journal-title":"Semin Thromb Hemost"},{"issue":"10141","key":"393_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","volume":"392","author":"M Cecconi","year":"2018","unstructured":"Cecconi M, Evans L, Levy M, Rhodes A (2018) Sepsis and septic shock. Lancet 392(10141):75\u201387","journal-title":"Lancet"},{"issue":"6","key":"393_CR50","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S2213-2600(20)30124-7","volume":"8","author":"K Reddy","year":"2020","unstructured":"Reddy K, Sinha P, O\u2019Kane CM, Gordon AC, Calfee CS, McAuley DF (2020) Subphenotypes in critical care: Translation into clinical practice. Lancet Respir Med 8(6):631\u2013643","journal-title":"Lancet Respir Med"},{"issue":"12","key":"393_CR51","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13(12):862\u201374","journal-title":"Nat Rev Immunol"},{"issue":"23","key":"393_CR52","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1001\/jama.2011.1829","volume":"306","author":"JS Boomer","year":"2011","unstructured":"Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD 2nd, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS (2011) Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306(23):2594\u2013605","journal-title":"JAMA"},{"issue":"5","key":"393_CR53","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1160\/TH05-07-0530","volume":"95","author":"JN Hoffmann","year":"2006","unstructured":"Hoffmann JN, Wiedermann CJ, Juers M, Ostermann H, Kienast J, Briegel J, Strauss R, Warren BL, Opal SM, KyberSept investigators (2006) Benefit\/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin. Thromb Haemost 95(5):850\u20136","journal-title":"Thromb Haemost"},{"issue":"1","key":"393_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1415-1","volume":"20","author":"K Yamakawa","year":"2016","unstructured":"Yamakawa K, Umemura Y, Hayakawa M, Kudo D, Sanui M, Takahashi H, Yoshikawa Y, Hamasaki T, Fujimi S, Japan Septic Disseminated Intravascular Coagulation (J-Septic DIC) study group (2016) Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan. Crit Care 20(1):229","journal-title":"Crit Care"},{"issue":"1","key":"393_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-021-00842-4","volume":"11","author":"B Fran\u00e7ois","year":"2021","unstructured":"Fran\u00e7ois B, Fiancette M, Helms J, Mercier E, Lascarrou JB, Kayanoki T, Tanaka K, Fineberg D, Vincent JL, Wittebole X (2021) Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET. Ann Intensive Care 11(1):53","journal-title":"Ann Intensive Care"},{"issue":"1","key":"393_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-025-01434-2","volume":"15","author":"A Curtiaud","year":"2025","unstructured":"Curtiaud A, Iba T, Angles-Cano E, Meziani F, Helms J (2025) Biomarkers of sepsis-induced coagulopathy: diagnostic insights and potential therapeutic implications. Ann Intensive Care 15(1):12","journal-title":"Ann Intensive Care"},{"issue":"11","key":"393_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-016-0544-7","volume":"18","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Rubenfeld GD (2016) Understanding long-term outcomes following sepsis: implications and challenges. Curr Infect Dis Rep 18(11):37","journal-title":"Curr Infect Dis Rep"},{"issue":"22","key":"393_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15222887","volume":"15","author":"X Jin","year":"2025","unstructured":"Jin X, Shen H, Zhou P, Yang J, Yang S, Ni H, Yu Y, Zhang Z (2025) Research progress on sepsis diagnosis and monitoring based on omics technologies: a review. Diagnostics 15(22):2887","journal-title":"Diagnostics"},{"issue":"1","key":"393_CR59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13613-025-01524-1","volume":"15","author":"V Bourika","year":"2025","unstructured":"Bourika V, Rekoumi EA, Giamarellos-Bourboulis EJ (2025) Biomarkers to guide sepsis management. Ann Intensive Care 15(1):103","journal-title":"Ann Intensive Care"},{"issue":"4","key":"393_CR60","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S2213-2600(23)00330-2","volume":"12","author":"S Cajander","year":"2024","unstructured":"Cajander S, Kox M, Scicluna BP, Weigand MA, Mora RA, Floh\u00e9 SB, Martin-Loeches I, Lachmann G, Girardis M, Garcia-Salido A, Brunkhorst FM, Bauer M, Torres A, Cossarizza A, Monneret G, Cavaillon JM, Shankar-Hari M, Giamarellos-Bourboulis EJ, Winkler MS, Skirecki T, Osuchowski M, Rubio I, Bermejo-Martin JF, Schefold JC, Venet F (2024) Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine. Lancet Respir Med 12(4):305\u2013322","journal-title":"Lancet Respir Med"},{"key":"393_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2019.120270","volume":"207","author":"N Tasi\u0107","year":"2020","unstructured":"Tasi\u0107 N, Paix\u00e3o TRLC, Gon\u00e7alves LM (2020) Biosensing of D-dimer, making the transition from the central hospital laboratory to bedside determination. Talanta 207:120270","journal-title":"Talanta"},{"issue":"1","key":"393_CR62","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s13054-025-05684-1","volume":"29","author":"LR Van Nynatten","year":"2025","unstructured":"Van Nynatten LR, Bokhary D, Wong MYS, Wang J, Fero H, McChesney C, Fiorini K, Blake L, Fraser DD, Slessarev M, Leligdowicz A, Rochwerg B, Basmaji J (2025) Predictive enrichment using biomarkers in studies of critically-ill patients with sepsis: a systematic review. Crit Care 29(1):504","journal-title":"Crit Care"},{"issue":"1","key":"393_CR63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-024-01760-0","volume":"9","author":"XP Duan","year":"2024","unstructured":"Duan XP, Qin BD, Jiao XD, Liu K, Wang Z, Zang YS (2024) New clinical trial design in precision medicine: discovery, development and direction. Signal Transduct Target Ther 9(1):57","journal-title":"Signal Transduct Target Ther"},{"key":"393_CR64","doi-asserted-by":"publisher","DOI":"10.14789\/ejmj.jmj25-0043-r","author":"YC Yeh","year":"2025","unstructured":"Yeh YC (2025) Endotoxin hemoperfusion as an adjuvant therapy for sepsis: lessons from the TIGRIS trial. Juntendo Med J. https:\/\/doi.org\/10.14789\/ejmj.jmj25-0043-r","journal-title":"Juntendo Med J"},{"issue":"5","key":"393_CR65","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(15)70112-X","volume":"15","author":"J Cohen","year":"2015","unstructured":"Cohen J, Vincent JL, Adhikari NK, Machado FR, Angus DC, Calandra T, Jaton K, Giulieri S, Delaloye J, Opal S, Tracey K, van der Poll T, Pelfrene E (2015) Sepsis: a roadmap for future research. Lancet Infect Dis 15(5):581\u2013614","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"393_CR66","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2023.537","volume":"7","author":"AM Kaizer","year":"2023","unstructured":"Kaizer AM, Belli HM, Ma Z, Nicklawsky AG, Roberts SC, Wild J, Wogu AF, Xiao M, Sabo RT (2023Apr 28) Recent innovations in adaptive trial designs: a review of design opportunities in translational research. J Clin Transl Sci 7(1):e125","journal-title":"J Clin Transl Sci"},{"issue":"10","key":"393_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/life15101517","volume":"15","author":"JL Vincent","year":"2025","unstructured":"Vincent JL (2025) The 15th anniversary of Life-Sepsis Trials. Life 15(10):1517","journal-title":"Life"},{"issue":"6","key":"393_CR68","doi-asserted-by":"publisher","first-page":"406","DOI":"10.14789\/ejmj.JMJ25-0043-R","volume":"71","author":"YC Yeh","year":"2025","unstructured":"Yeh YC, Nagakari K, Iba T (2025Dec 10) Endotoxin hemoperfusion as an adjuvant therapy for sepsis: lessons from the TIGRIS trial. Juntendo Med J 71(6):406\u2013410","journal-title":"Juntendo Med J"}],"container-title":["Journal of Anesthesia, Analgesia and Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44158-026-00393-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-026-00393-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-026-00393-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:02:50Z","timestamp":1782086570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s44158-026-00393-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["393"],"URL":"https:\/\/doi.org\/10.1186\/s44158-026-00393-9","relation":{},"ISSN":["2731-3786"],"issn-type":[{"value":"2731-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}